Viewing Study NCT03442556


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2026-01-22 @ 1:18 PM
Study NCT ID: NCT03442556
Status: TERMINATED
Last Update Posted: 2025-06-12
First Post: 2018-02-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
Sponsor: University of Washington
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module